| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Immunology |
Departments of 1 Cellular Stress Biology, 2 Urologic Oncology, and 3 Immunology, Roswell Park Cancer Institute, Buffalo, New York
Requests for reprints: Xiang-Yang Wang, Department of Cellular Stress Biology, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, NY 14263. Phone: 716-845-2375; E-mail: xiang-yang.wang{at}roswellpark.org.
The scavenger receptor-A (SR-A), originally recognized by its ability to internalize modified lipoproteins, has largely been studied in relation to atherosclerosis as well as innate immunity against pathogen infection. SR-A was recently shown to be a receptor on antigen-presenting cell for heat shock protein (HSP) and was implicated in the cross-presentation of HSP-chaperoned antigens. Here, we show that SR-A is not required for antitumor immunity generated by HSP-based (e.g., grp170) vaccine approaches in vivo. The lack of SR-A significantly enhances HSP- or lipopolysaccharide-mediated vaccine activities against poorly immunogenic tumors, indicating that SR-A is able to attenuate immunostimulatory effects of adjuvants or "danger" molecules. The improved antitumor response in SR-A knockout mice is correlated with an increased antigen-specific T-cell response. Moreover, SR-A–deficient dendritic cells are more responsive to inflammatory stimuli and display a more effective antigen-presenting capability compared with wild-type cells. This is the first report illustrating that SR-A negatively regulates antigen-specific antitumor immunity, which has important clinical implications in vaccine design for cancer immunotherapy. [Cancer Res 2007;67(10):4996–5002]
This article has been cited by other articles:
|
|
 |
|
  J. R. Riddell, X.-Y. Wang, H. Minderman, and S. O. Gollnick Peroxiredoxin 1 Stimulates Secretion of Proinflammatory Cytokines by Binding to TLR4 J. Immunol., January 15, 2010; 184(2): 1022 - 1030. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Gong, B. Zhu, A. Murshid, H. Adachi, B. Song, A. Lee, C. Liu, and S. K. Calderwood T Cell Activation by Heat Shock Protein 70 Vaccine Requires TLR Signaling and Scavenger Receptor Expressed by Endothelial Cells-1 J. Immunol., September 1, 2009; 183(5): 3092 - 3098. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Zhu, X. Liu, L. S. Treml, M. P. Cancro, and B. D. Freedman Mechanism and Regulatory Function of CpG Signaling via Scavenger Receptor B1 in Primary B Cells J. Biol. Chem., August 21, 2009; 284(34): 22878 - 22887. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Yi, X. Yu, P. Gao, Y. Wang, S.-H. Baek, X. Chen, H. L. Kim, J. R. Subjeck, and X.-Y. Wang Pattern recognition scavenger receptor SRA/CD204 down-regulates Toll-like receptor 4 signaling-dependent CD8 T-cell activation Blood, June 4, 2009; 113(23): 5819 - 5828. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-O Jin, H.-Y. Park, Q. Xu, J.-I. Park, T. Zvyagintseva, V. A. Stonik, and J.-Y. Kwak Ligand of scavenger receptor class A indirectly induces maturation of human blood dendritic cells via production of tumor necrosis factor-{alpha} Blood, June 4, 2009; 113(23): 5839 - 5847. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. M. Srivastava, C. Varalakshmi, and A. Khar The Ischemia-Responsive Protein 94 (Irp94) Activates Dendritic Cells through NK Cell Receptor Protein-2/NK Group 2 Member D (NKR-P2/NKG2D) Leading to Their Maturation J. Immunol., January 15, 2008; 180(2): 1117 - 1130. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
